Vaxcyte, Inc (PCVX)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | PHARMACEUTICALS |
| SIC: | BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) |
| CEO: | Grant E. Pickering |
| Employees: | 160 |
| Web site: | vaxcyte.com |
|
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
650-837-0111
| |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials. The company was formerly known as SutroVax, Inc.
Please log in first to see chart